Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2008 1
2009 1
2010 1
2012 1
2013 1
2014 1
2015 3
2016 2
2017 1
2018 3
2019 5
2020 3
2021 5
2022 4
2023 2
2024 4
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder.
Cameron AP, Chung DE, Dielubanza EJ, Enemchukwu E, Ginsberg DA, Helfand BT, Linder BJ, Reynolds WS, Rovner ES, Souter L, Suskind AM, Takacs E, Welk B, Smith AL. Cameron AP, et al. J Urol. 2024 Jul;212(1):11-20. doi: 10.1097/JU.0000000000003985. Epub 2024 Apr 23. J Urol. 2024. PMID: 38651651
PURPOSE: The purpose of this guideline is to provide evidence-based guidance to clinicians of all specialties on the evaluation, management, and treatment of idiopathic overactive bladder (OAB). The guideline informs the reader on valid diagnostic processes and prov …
PURPOSE: The purpose of this guideline is to provide evidence-based guidance to clinicians of all specialties on the evaluation, management, …
A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus.
Luciano MG, Williams MA, Hamilton MG, Katzen HL, Dasher NA, Moghekar A, Hua J, Malm J, Eklund A, Alpert Abel N, Raslan AM, Elder BD, Savage JJ, Barrow DL, Shahlaie K, Jensen H, Zwimpfer TJ, Wollett J, Hanley DF, Holubkov R; PENS Trial Investigators and the Adult Hydrocephalus Clinical Research Network. Luciano MG, et al. N Engl J Med. 2025 Dec 4;393(22):2198-2209. doi: 10.1056/NEJMoa2503109. Epub 2025 Sep 16. N Engl J Med. 2025. PMID: 40960253 Free PMC article. Clinical Trial.
Secondary outcomes were the change at 3 months in the Tinetti scale total score (range, 0 to 28; lower scores indicate worse gait and balance), Montreal Cognitive Assessment (MoCA) score (range, 0 to 30; lower scores indicate worse cognition), and Overactive Bladder …
Secondary outcomes were the change at 3 months in the Tinetti scale total score (range, 0 to 28; lower scores indicate worse gait and balanc …
The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause.
Kaufman MR, Ackerman AL, Amin KA, Coffey M, Danan E, Faubion SS, Hardart A, Goldstein I, Ippolito GM, Northington GM, Powell CR, Rubin RS, Westney OL, Wilson TS, Lee UJ. Kaufman MR, et al. J Urol. 2025 Sep;214(3):242-250. doi: 10.1097/JU.0000000000004589. Epub 2025 Apr 29. J Urol. 2025. PMID: 40298120
There has not been a consensus reached about the number or type of symptoms needed to diagnose GSM, and the associated urinary symptoms are also linked with other common urologic conditions such as overactive bladder. This guideline provides information to clinician …
There has not been a consensus reached about the number or type of symptoms needed to diagnose GSM, and the associated urinary symptoms are …
Evaluation and Treatment of Overactive Bladder in Women.
Raju R, Linder BJ. Raju R, et al. Mayo Clin Proc. 2020 Feb;95(2):370-377. doi: 10.1016/j.mayocp.2019.11.024. Mayo Clin Proc. 2020. PMID: 32029089 Review.
Overactive bladder (OAB) is a symptom complex that includes urinary urgency, frequency, urgency incontinence, and nocturia. ...
Overactive bladder (OAB) is a symptom complex that includes urinary urgency, frequency, urgency incontinence, and nocturia. .. …
The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder.
Cameron AP, Chung DE, Dielubanza EJ, Enemchukwu E, Ginsberg DA, Helfand BT, Linder BJ, Reynolds WS, Rovner ES, Souter L, Suskind AM, Takacs E, Welk B, Smith AL. Cameron AP, et al. Neurourol Urodyn. 2024 Nov;43(8):1742-1752. doi: 10.1002/nau.25532. Epub 2024 Jul 15. Neurourol Urodyn. 2024. PMID: 39010271 Free article.
PURPOSE: The purpose of this guideline is to provide evidence-based guidance to clinicians of all specialties on the evaluation, management, and treatment of idiopathic overactive bladder (OAB). The guideline informs the reader on valid diagnostic processes and prov …
PURPOSE: The purpose of this guideline is to provide evidence-based guidance to clinicians of all specialties on the evaluation, management, …
Atypical Applications of Neuromodulation for Non-Painful Conditions.
Brown A, Lam L, Huh B, D'Souza RS, Javed S. Brown A, et al. Curr Pain Headache Rep. 2025 May 3;29(1):82. doi: 10.1007/s11916-025-01389-w. Curr Pain Headache Rep. 2025. PMID: 40317388 Review.
PURPOSE OF REVIEW: This narrative review explores the expanding applications of neuromodulation beyond pain management, focusing on its use in treating non-painful conditions such as heart failure, renal failure, spinal cord injuries, overactive bladder syndrome, an …
PURPOSE OF REVIEW: This narrative review explores the expanding applications of neuromodulation beyond pain management, focusing on its use …
Trospium chloride: a quaternary amine with unique pharmacologic properties.
Pak RW, Petrou SP, Staskin DR. Pak RW, et al. Curr Urol Rep. 2003 Dec;4(6):436-40. doi: 10.1007/s11934-003-0023-1. Curr Urol Rep. 2003. PMID: 14622495 Review.
The mainstay of pharmacologic treatment of overactive bladder is anticholinergic therapy. Cholinergic blockade is efficacious in decreasing the symptoms of urgency, frequency, and urge incontinence, but also is associated with undesirable side effects such as dry mo …
The mainstay of pharmacologic treatment of overactive bladder is anticholinergic therapy. Cholinergic blockade is efficacious …
Financial Toxicity for Female Patients with Urinary Incontinence.
Lee YS, Khan AA. Lee YS, et al. Curr Urol Rep. 2023 Jan;24(1):33-39. doi: 10.1007/s11934-022-01130-9. Epub 2022 Dec 17. Curr Urol Rep. 2023. PMID: 36527587 Review.
Pharmacologic management is generally second-line for overactive bladder, but anti-muscarinic drugs and beta-3 agonists are cost-effective depending on willingness-to-pay and the health system in which they are acquired, respectively. ...
Pharmacologic management is generally second-line for overactive bladder, but anti-muscarinic drugs and beta-3 agonists are co …
A systematic review and in silico study of potential genetic markers implicated in cases of overactive bladder.
Isali I, McClellan P, Wong TR, Sun C, Stout AC, Schumacher FR, Markt S, Wilfred Wu CH, Penney KL, El-Nashar S, Hijaz A, Sheyn D. Isali I, et al. Am J Obstet Gynecol. 2023 Jan;228(1):36-47.e3. doi: 10.1016/j.ajog.2022.07.044. Epub 2022 Aug 4. Am J Obstet Gynecol. 2023. PMID: 35932882 Free PMC article.
OBJECTIVE: The contribution of genetic factors to the presence of an overactive bladder is recognized. This study aimed to (1) assemble and synthesize available data from studies assessing differential gene expression in patients with overactive bladder …
OBJECTIVE: The contribution of genetic factors to the presence of an overactive bladder is recognized. This study aimed to (1) …
40 results